Mini lead aims to supercharge heart failure therapy

NCT ID NCT03750058

Completed Disease control Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a new, very small lead (under 2 French) designed to improve cardiac resynchronization therapy (CRT) for heart failure. In 20 patients getting a standard CRT device, doctors temporarily placed the new lead to see if it could pace the heart's left ventricle from multiple spots. The study measured how often the lead worked well and checked for any immediate problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: new micro multipolar lead (device)
What this could lead to: If successful, this could lead to a more precise and less invasive way to deliver cardiac resynchronization therapy for heart failure patients.
What could go wrong: This is a very small pilot study with only 20 patients, so results may not apply to everyone. The lead is new and could have unknown risks or fail to work as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC RESYNCHRONISATION THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC RESYNCHRONISATION THERAPY

Contacts and locations

Locations

Bordeaux University Hospital

Bordeaux, France
Lille University Hospital

Lille, France
Rennes University Hospital

Rennes, France
Rouen University Hospital

Rouen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.